Health
Exploring the safety and immunogenicity of KD-414, a novel SARS-CoV-2 vaccine
Exploring the safety and immunogenicity of KD-414, a novel SARS-CoV-2 vaccine
In a new study, researchers assessed the immunogenicity and safety of KD-414, an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine.